Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials by April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp

Subjects: Get full text

Does STN-DBS in Parkinson's Disease affect cognition? A case-control neuropsychological study and clinical considerations by Chiara Longo, Luca Zigiotto, Daniele Luigi Romano, Silvio Sarubbo, Francesco Corsini, Ruggero Bacchin, Donatella Ottaviani, Raffaella Di Giacopo, Umberto Rozzanigo, Bryan Bertoldi, Maria Chiara Malaguti, Costanza Papagno

Subjects: Get full text

Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease by Ricardo Nitrini, Adalberto Studart-Neto

Subjects: Get full text

Estimating a minimum clinically important difference for the Developmental Behaviour Checklist – parent report by Daniel L. Sutherland, Emma L. Taylor, Emma L. Taylor, Kylie M. Gray, Kylie M. Gray, Richard P. Hastings, Richard P. Hastings, Amanda Allard, Joanna Carr, Joanna Griffin, Joanna Griffin, Nicola McMeekin, Elizabeth Randell, Daisy Russell, Bronwen Willoughby-Richards, Jeanne Wolstencroft, Paul A. Thompson

Subjects: Get full text

Disentangling minimum clinically important difference for an individual and a population in the treatment of Alzheimer's disease by Changyu Shen, Robert W. Platt, Shibeshih Belachew, Hiroko H. Dodge

Subjects: Get full text

The variability of minimum clinically important difference, substantial clinical benefit, and patient acceptable symptom state thresholds for Patient-Reported Outcome Measures in t... by Auston R. Locke, MPH, Avanish Yendluri, BS, Graham Sabo, BA, Niklas H. Koehne, BA, Alexander C. Lee, MD, Ibikari Legg-Jack, BS, Michael N. Megafu, DO, MPH, Xinning Li, MD, John D. Kelly, IV, MD, Robert L. Parisien, MD

Subjects: “…Minimum clinically important difference…”
Get full text

Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepress... by Hikaru Hori, Masako Shiosakai, Yoshiyuki Shibasaki, Kentaro Yamato, Kentaro Yamato, Yilong Zhang

Subjects: Get full text